Treatment of hereditary haemorrhagic telangiectasia with bevacizumab – what more needs to be known?
Introduction: Hereditary haemorrhagic telangiectasia (HHT) is a rare multi-organ vascular disease. It is characterised by mucocutaneous telangiectasia, epistaxis, and arteriovenous malformations. Some 70% of patients with HHT are thought to have issues with gastrointestinal (GI) bleeding. Traditiona...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SMC MEDIA SRL
2023-12-01
|
| coleção: | European Journal of Case Reports in Internal Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4219 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|